Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study | BMC Cancer User montaukwhaler, in the non small cell lung cancer subreddit, 15 Dec 2018